vimarsana.com

uniQure (NASDAQ:QURE – Free Report) – Equities researchers at HC Wainwright upped their Q3 2023 earnings estimates for uniQure in a note issued to investors on Thursday, August 3rd. HC Wainwright analyst P. Trucchio now anticipates that the biotechnology company will post earnings of ($1.34) per share for the quarter, up from their previous forecast […]

Related Keywords

,Rachelle Suzanne Jacques ,Pierre Caloz ,Hightower Advisors ,International Biotechnology Trust ,Wells Fargo Company ,Lord Abbett ,Blair William Co ,Securities Exchange Commission ,Free Report ,Get Free Report ,Wells Fargo ,Qure Trading Down ,Biotechnology Trust ,Tower Advisors ,Director Rachelle Suzanne Jacques ,Exchange Commission ,Qure Daily ,Uniqure ,Nasdaq Qure ,Qure ,Medical ,Earnings Estimates ,Hc Wainwright ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.